About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.46 (-0.22%)
SVRA NASDAQ Savara Inc
Savara Inc share price
Atividade de preço de SVRA
Último preço
$ 4,460
Variação (24h)
-0,01 USD (0,22%)
Volume
2.97M
Volume (média 4 sem.)
-
Abertura
$ 4,60
Variação do dia
$ 4,35 - $ 4,60
Fechamento anterior
$ 4,47
Último negócio
17 Nov, 8:57 pm GMT+0
Atrasado
17 Nov, 8:57 pm GMT+0
SVRA price performance
Atrasado
17 Nov, 8:57 pm GMT+0
SVRA details
quote.marketSignals